期刊文献+

Change of choline compounds in sodium selenite-induced apoptosis of rats used as quantitative analysis by in vitro 9.4T MR spectroscopy 被引量:13

Change of choline compounds in sodium selenite-induced apoptosis of rats used as quantitative analysis by in vitro 9.4T MR spectroscopy
下载PDF
导出
摘要 AIM: To study liver cell apoptosis caused by the toxicity of selenium and observe the alteration of choline compounds using in vitro 9.4T high resolution magnetic resonance spectroscopy. METHODS: Twenty male Wistar rats were randomly divided into two groups. The rats in the treatment group were intraperitoneally injected with sodium selenite and the control group with distilled water. All rats were sacrifi ced and the livers were dissected. 1H-MRS data were collected using in vitro 9.4T high resolution magnetic resonance spectrometer. Spectra were processed using XWINNMR and MestRe-c 4.3. HE and TUNEL staining was employed to detect and confi rm the change of liver cells. RESULTS: Good 1H-MR spectra of perchloric acid extract from liver tissue of rats were obtained. The conventional metabolites were detected and assigned. Concentrations of different ingredient choline compounds in treatment group vs control group were as follows: total choline compounds,5.08 ± 0.97 mmol/L vs 3.81 ± 1.16 mmol/L (P = 0.05); and free choline,1.07 ± 0.23 mmol/L vs 0.65 ± 0.20 mmol/L (P = 0.00). However,there was no statistical signif icance between the two groups. The hepatic sinus and cellular structure of hepatic cells in treatmentgroup were abnormal. Apoptosis of hepatic cells was confi rmed by TUNEL assay. CONCLUSION: High dose selenium compounds can cause the rat liver lesion and induce cell apoptosis in vivo. High resolution 1H-MRS in vitro can detect diversified metabolism. The changing trend for different ingredient of choline compounds is not completely the same at early period of apoptosis. AIM: TO study liver cell apoptosis caused by the toxicity of selenium and observe the alteration of choline compounds using in vitro 9.4T high resolution magnetic resonance spectroscopy. METHODS Twenty male Wistar rats were randomly divided into two groups. The rats in the treatment group were intraperitoneally injected with sodium selenite and the control group with distilled water. All rats were sacrificed and the livers were dissected. 1H-MRS data were collected using in vitro 9.4T high resolution magnetic resonance spectrometer. Spectra were processed using XWINNMR and MestRe-c 4.3. HE and TUNEL staining was employed to detect and confirm the change of liver cells. RESULTS: Good 1H-MR spectra of perchloric acid extract from liver tissue of rats were obtained. The conventional metabolites were detected and assigned. Concentrations of different ingredient choline compounds in treatment group vs control group were as follows: total choline compounds, 5.08 ± 0.97 mmol/L vs 3.81±1.16 mmol/L (P = 0.05); and free choline, 1.07 ± 0.23 mmol/L vs 0.65± 0.20 mmol/L (P = 0.00). However, there was no statistical significance between the two groups. The hepatic sinus and cellular structure of hepatic cells in treatmentgroup were abnormal. Apoptosis of hepatic cells was confirmed by TUNEL assay. CONCLUSION High dose selenium compounds can cause the rat liver lesion and induce cell apoptosis in vivo. High resolution 1H-MRS in vitro can detect diversified metabolism. The changing trend for different ingredient of choline compounds is not completely the same at early period of apoptosis.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第24期3891-3896,共6页 世界胃肠病学杂志(英文版)
基金 The National Natural Science Foundation of China,No.30570480
关键词 肝细胞凋亡 胆碱混合物 硅酸钠 数量分析 Apoptosis of liver cell Choline compounds Sodium selenite In vitro ^1H-MRS Quantitative analysis
  • 相关文献

参考文献3

二级参考文献61

  • 1[1]Neuschwander-Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology 2003; 37:1202-1219
  • 2[2]Szczepaniak LS,Nurenberg P,Leonard D,Browning JD,Reingold JS,Grundy S,Hobbs HH,Dobbins RL.Magnetic resonance spectroscopy to measure hepatic triglyceride content:prevalence of hepatic steatosis in the general population.Am J Physiol Endocrinol Metab 2005; 288:E462-E468
  • 3[3]Wanless IR,Lentz JS.Fatty liver hepatitis (steatohepatitis) and obesity:an autopsy study with analysis of risk factors.Hepatology 1990; 12:1106-1110
  • 4[4]Powell EE,Cooksley WG,Hanson R,Searle J,Halliday JW,Powell LW.The natural history of nonalcoholic steatohepatitis:a follow-up study of forty-two patients for up to 21 years.Hepatology 1990; 11:74-80
  • 5[5]Marchesini G,Bugianesi E,Forlani G,Cerrelli F,Lenzi M,Manini R,Natale S,Vanni E,Villanova N,Melchionda N,Rizzetto M.Nonalcoholic fatty liver,steatohepatitis,and the metabolic syndrome.Hepatology 2003; 37:917-923
  • 6[6]Bugianesi E,Marzocchi R,Villanova N,Marchesini G.Nonalcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH):treatment.Best Pract Res Clin Gastroenterol 2004;18:1105-1116
  • 7[7]Andersen T,Gluud C,Franzmann MB,Christoffersen P.Hepatic effects of dietary weight loss in morbidly obese subjects.J Hepatol 1991; 12:224-229
  • 8[8]Dixon JB,Bhathal PS,Hughes NR,O'Brien PE.Nonalcoholic fatty liver disease:Improvement in liver histological analysis with weight loss.Hepatology 2004; 39:1647-1654
  • 9[9]Luyckx FH,Desaive C,Thiry A,Dewe W,Scheen AJ,Gielen JE,Lefebvre PJ.Liver abnormalities in severely obese subjects:effect of drastic weight loss after gastroplasty.Int J Obes Relat Metab Disord 1998; 22:222-226
  • 10[10]Petersen KF,Dufour S,Befroy D,Lehrke M,Hendler RE,Shulman GI.Reversal of nonalcoholic hepatic steatosis,hepatic insulin resistance,and hyperglycemia by moderate weight reduction in patients with type 2 diabetes.Diabetes 2005; 54:603-608

共引文献19

同被引文献44

引证文献13

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部